Chemplast Sanmar Limited Valuation
CHEMPLASTS · Chemicals · Current price ₹214.5
Is Chemplast Sanmar Limited undervalued?
We estimate the fair value of Chemplast Sanmar Limited at ₹185 per share, against a market price of ₹171. That puts the share price about +8.0% below our estimate, at low confidence. This is our view of what the business is worth, not a target price or a forecast of where the share price will go.
How this fair value is calculated
This estimate comes from 1 method: Discounted cash flow (2-stage) (₹185). Each is weighted by how well its inputs held up for this company. The full working, including the assumptions and what data was missing, is set out below.
The range around this estimate
Our estimate for Chemplast Sanmar Limited spans ₹167 to ₹204. That range is wide, which is the honest signal here: read the range rather than the single number. A margin of safety means buying meaningfully below the estimate: the wider the range, the more room the assumptions leave for error.
Valuation multiples
Chemplast Sanmar Limited trades at a P/E of -7.1x and a P/B of -27.8x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
How we got this fair value
Every number below is part of the same estimate for Chemplast Sanmar Limited. Nothing here is a target price or a forecast of where the share price will go.
The inputs are thin or the models disagree sharply. This is our least reliable kind of estimate, so read the range rather than the single number.
Estimate range ₹167 – ₹204
Why this method for this business
The company operates in the specialty chemicals sector, which is a subset of the commodities sector. EV/Sales is appropriate for revenue-driven businesses with stable cash flows, while DCF is suitable for assessing intrinsic value based on discounted cash flows.
The models behind the number
Each method is weighted by how well its inputs held up for this company.
Intrinsic value from 2-stage discounted cash flows (primary for asset-light / normal businesses); FCFE path
required inputs missing
- Discounted cash flow (2-stage) was already used but EV/Sales provides a complementary valuation lens for revenue-based businesses.
What was missing
- Lack of forward EPS data for normalization
- Limited analyst coverage for EV/Sales model
What drives it
12 inputs, grouped by how strong each claim is
- FCF_0 (normalized)
- 269.5 ₹cr
- Net debt
- 1,952 ₹cr
fcf_norm (median ≤5y positive)
gross debt (cash n/a)
- Discount rate (r)
- 15.53%
- Beta
- 1.15
COE (building-block)
bottom-up industry
- Stage-1 start growth
- 8%
- Fade shape
- linear
- Terminal growth (g)
- 4.86%
- Stage-1 years
- 8 y
lifecycle-floor
lifecycle Turnaround
macro terminal × quality premium
lifecycle Turnaround horizon
- Lifecycle stage
- Turnaround
- Quality premium
- 0.972×
forecast engine (L20)
moat None + capital allocation
- Path
- FCFE
- Terminal-value fraction
- 0.47
computed (D/E vs 0.8)
PV_TV / (PV_1+PV_TV)
Who computed this
A language model (qwen3:8b) selects the valuation method and the judgement inputs for Chemplast Sanmar Limited: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.
Estimated 15 Sept 2026. Re-run as new financials and news arrive.
How we value stocks
We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.
Read the full fair-value methodologyUnderstand the ratios
More on Chemplast Sanmar Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.